Berry Genomics Co.,Ltd
SHZ: 000710.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yang Gao
- Employees
- 1,448
- Headquarters
- Beijing, China
- IPO year
- 1997
- Market cap
- CN¥3.9B
- Website
- https://www.berrygenomics.com
Loading 000710…
Loading profile data…Frequently asked questions about 000710
What does Berry Genomics Co.,Ltd (000710.SZ) do?
Berry Genomics Co.,Ltd, a genomics company, develops and commercializes technologies for the life sciences and clinical applications in China. The company offers NGS- based tests for various genetic diseases and cancers from preconception to adulthood; WES test for inherited pathogenic mutations in the GCH1 gene associated with the metabolic dis...
Where does 000710.SZ trade?
Berry Genomics Co.,Ltd (000710.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000710.SZ in?
Berry Genomics Co.,Ltd (000710.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Berry Genomics Co.,Ltd?
Yang Gao is the chief executive officer of Berry Genomics Co.,Ltd (000710.SZ).
Where is Berry Genomics Co.,Ltd headquartered?
Berry Genomics Co.,Ltd is headquartered in China.
Does 000710.SZ pay a dividend?
Berry Genomics Co.,Ltd (000710.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 000710.SZ go public?
Berry Genomics Co.,Ltd (000710.SZ) completed its initial public offering in 1997.